US Esoteric Testing Market Size and Forecasts (2020-2030)

According to our new research study on ” US Esoteric Testing Market Size and Forecast (2020–2030), Country Share, Trend, and Growth Opportunity Analysis – by Type, Technology, and End User,” the market is expected to grow from US$ 10.382 billion in 2022 to US$ 31.274 billion by 2030; the market is estimated to record a CAGR of 14.8% during 2022–2030. The report highlights the major factors driving the US’s esoteric testing market growth and prominent players with their developments in the market.

Based on technology, the US esoteric testing market is segmented into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, DNA sequencing, flow cytometry, and others. The chemiluminescence immunoassay segment held the largest market share in 2022. The enzyme-linked immunosorbent assay segment is anticipated to register the highest CAGR of 18.7% during 2022–2030. An immunoassay exploits the principles of biochemistry for the detection and measurement of an analyte, which can be large proteins, antibodies (produced in response to an infection), or small molecules. These highly adaptable assays can be applied to determine various types of analytes, depending on the needs of users. Chemiluminescent immunoassays are a type of standard enzyme immunoassays (EIA), representing the application of biochemical techniques in immunology.
Direct chemiluminescent methods use luminophore markers, while indirect methods use enzyme markers. The key advantages of chemiluminescent analytical methods include a wide application range, high signal intensity, absence of interfering emissions (high specificity), rapid acquisition of analytical signals, high stability of reagents and their conjugates, low consumption of reagents, random access, reduced incubation time, and full compatibility with immunology assay protocols.

The US esoteric testing market, by type, is segmented into infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. The oncology testing segment held the largest market share in 2022. The infectious disease testing segment is anticipated to register the highest CAGR from 2022 to 2030. Infectious diseases are transmitted in multiple ways; thus, on-time diagnosis and treatment are the key to limiting their transmission. Laboratory tests are the only way to confirm the diagnosis of an infection. Some inexpensive and convenient blood tests can diagnose Influenza, Lyme disease, Epstein-Barr virus infection, and so on. Disease-causing bacteria and viruses are easily identified by genetic testing. Major types of tests performed in labs include culturing, microscopy, immunologic tests, nucleic acid–based identification methods, and non-nucleic acid-based identification methods.
Polymerase chain reaction (PCR) is an example of an esoteric test employed for the identification of infectious diseases. This technique is employed to make multiple copies of a particular gene from the infection-causing microorganisms, making their identification easy. PCR tests are the “gold standard” in COVID-19 testing. As per Our World in Data stats, 909.44 million RT-PCR tests were performed in the US till June 2022.

Based on end users, the US esoteric testing market is segmented into hospitals and laboratories, as well as independent and reference laboratories. The hospitals and laboratories segment held a larger share of the market in 2022. It is further expected to register a higher CAGR of 15.2% during 2022–2030. Almost all hospitals have a laboratory whose operations are proportional in size to the population they serve. Hospital laboratories need to process hundreds of samples in a limited timeframe. This includes all the tests that are required during emergencies and are conducted in high volumes, such as cardiac biomarker (troponin) tests, wherein results are needed rapidly for effective patient care. The workload in hospital labs can be divided on the basis of the type of testing. These facilities are staffed by personnel trained in particular specialties, which mainly include hematology, microbiology, chemistry, and blood banking. Other units may perform specialized tests using electron microscopy and immunohistochemistry, with a focus on surgical pathology and cytology (analyzing cell and tissue structure). Mayo Clinic in Rochester (US) is among the best facilities for the diagnosis of diabetes and endocrinology in the US. The clinic performs esoteric testing for endocrinology.

Georgia Esoteric & Molecular Laboratory LLC, Laboratory Corp of America Holdings, Quest Diagnostics Inc., National Medical Services Inc., OPKO Health Inc., ARUP Laboratories Inc., bioMONTR Labs, Athena Esoterix LLC, Stanford Hospital & Clinics, and Foundation Medicine Inc., among others are among the key companies operating in the US Esoteric Testing market.

Companies operating in the US’s esoteric testing market adopt various organic and inorganic strategies. Organic strategies mainly include product launch expansion and business planning. Mergers & acquisitions, partnerships, and collaborations are among the inorganic growth strategies witnessed in the US Esoteric Testing market. These developments allow the market players to expand their businesses, thereby contributing to the overall growth of the US esoteric testing market.
A few of the significant developments by key US Esoteric Testing market players are listed below.

• In March 2022, Waters Corporation launched the Xevo TQ Absolute system, a highly sensitive and compact benchtop tandem mass spectrometer. This latest mass spectrometer quantifies negatively ionizing compounds with up to 15 times greater sensitivity than its predecessor, with a 45% smaller size. Moreover, it consumes up to 50% less electricity and gas.
• In February 2021, Quest Diagnostics collaborated with Grail for its Galleri multicancer blood tests. Quest Diagnostics had plans to provide phlebotomy services using the Galleri multicancer early-detection blood tests.
• In January 2021, BioReference Laboratories, Inc., an OPKO Health (OPK) company, introduced Scarlet Health. It is an in-home, fully integrated digital platform that provides access to on-demand diagnostic services. Similar to devices that are used on a daily basis, Scarlet has been designed to confer ease of use, ubiquity, and convenience. The platform delivers an innovative, flexible, mobile alternative to traditional patient service centers or other draw locations when phlebotomy and other specimen collection services are needed.
• In September 2021, LabCorp acquired operating assets and intellectual property (IP) from Myriad Genetics’ autoimmune business unit, including the Vectra rheumatoid arthritis (RA) assay. With this acquisition, LabCorp is expected to bolster its scientific leadership in rheumatology.
• In 2020, Quest Diagnostics acquired Blueprint Genetics, an outreach laboratory service business of Memorial Hermann Health System. Via this multiyear acquisition agreement, Quest plans to offer professional laboratory management services for all 21 hospital laboratories of Memorial Hermann, which provide onsite rapid-response testing. Quest also plans to become the sole laboratory service provider for the Memorial Hermann Health Plan.
• In 2019, Sonic Healthcare acquired Aurora Diagnostics to augment its presence in the anatomical pathology specialty in the US.

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US Esoteric Testing Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 US PEST Analysis
5. US Esoteric Testing Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases
5.1.2 Growing Awareness of Early Detection of Medical Conditions
5.2 Key Market Restraints
5.2.1 Lack of Skilled Personnel and High Cost of Procedure
5.3 Key Market Opportunities
5.3.1 Strategic Initiatives by Market Players
5.4 Future Trends
5.4.1 Development in Genetic Testing Technologies and Increased Government Initiatives for Rare Diseases
5.5 Impact Analysis
6. US Esoteric Testing Market – Revenue and Forecast to 2030
6.1 US Esoteric Testing Market Revenue (US$ Mn), 2022 – 2030
6.1.1 US Esoteric Testing Market, by Type, 2020–2030 (US$ Million)
6.1.2 US Esoteric Testing Market, by Technology, 2020–2030 (US$ Million)
6.1.3 US Esoteric Testing Market, by End User, 2020–2030 (US$ Million)
7. US Esoteric Testing Market – Revenue and Forecast to 2030 – by Technology
7.1 Overview
7.2 US Esoteric Testing Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Chemiluminescence Immunoassay
7.3.1 Overview
7.3.2 Chemiluminescence Immunoassay: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Enzyme-Linked Immunosorbent Assay
7.4.1 Overview
7.4.2 Enzyme-Linked Immunosorbent Assay: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Mass Spectrometry
7.5.1 Overview
7.5.2 Mass Spectrometry: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Real-Time PCR
7.6.1 Overview
7.6.2 Real-Time PCR: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Flow Cytometry
7.7.1 Overview
7.7.2 Flow Cytometry: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.8 DNA Sequencing
7.8.1 Overview
7.8.2 DNA Sequencing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
8. US Esoteric Testing Market – Revenue and Forecast to 2030 – by Type
8.1 Overview
8.2 US Esoteric Testing Market Revenue Share, by Type 2022 & 2030 (%)
8.3 Infectious Disease Testing
8.3.1 Overview
8.3.2 Infectious Disease Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Endocrinology Testing
8.4.1 Overview
8.4.2 Endocrinology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Oncology Testing
8.5.1 Overview
8.5.2 Oncology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Toxicology Testing
8.6.1 Overview
8.6.2 Toxicology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Immunology Testing
8.7.1 Overview
8.7.2 Immunology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Neurology Testing
8.8.1 Overview
8.8.2 Neurology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
9. US Esoteric Testing Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 US Esoteric Testing Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals & Laboratories
9.3.1 Overview
9.3.2 Hospitals & Laboratories: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Independent & Reference Laboratories
9.4.1 Overview
9.4.2 Independent & Reference Laboratories: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
10. US Esoteric Testing Market –Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.3 Inorganic Developments
10.3.1 Overview
11. Company Profiles
11.1 Georgia Esoteric & Molecular Laboratory LLC
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Laboratory Corp of America Holdings
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Quest Diagnostics Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 National Medical Services Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 OPKO Health Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 ARUP Laboratories Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 bioMONTR Labs
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Athena Esoterix LLC
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Stanford Hospital & Clinics
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Foundation Medicine Inc
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

Table 1. US Esoteric Testing Market Segmentation
Table 2. US Esoteric Testing Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. US Esoteric Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. US Esoteric Testing Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. Organic Developments in the US Esoteric Testing Market
Table 6. Inorganic Developments in the US Esoteric Testing Market
Table 7. Glossary of Terms, US Esoteric Testing Market

Figure 1. US Esoteric Testing Market Segmentation
Figure 2. US – PEST Analysis
Figure 3. US Esoteric Testing Market: Key Industry Dynamics
Figure 4. US Esoteric Testing Market: Impact Analysis of Drivers and Restraints
Figure 5. US Esoteric Testing Market Revenue (US$ Mn), 2020 – 2030
Figure 6. US Esoteric Testing Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 7. Chemiluminescence Immunoassay: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Enzyme-Linked Immunosorbent Assay: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Mass Spectrometry: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Real-Time PCR: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Flow Cytometry: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. DNA Sequencing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. US Esoteric Testing Market Revenue Share, by Type 2022 & 2030 (%)
Figure 15. Infectious Disease Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Endocrinology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Oncology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Toxicology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Immunology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Neurology Testing: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. US Esoteric Testing Market Revenue Share, by End User 2022 & 2030 (%)
Figure 23. Hospitals & Laboratories: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Independent & Reference Laboratories: US Esoteric Testing Market – Revenue and Forecast to 2030 (US$ Million)